Cobra Biologics Appoints CSO
This article was originally published in Scrip
Executive Summary
International contract manufacturing organization Cobra Biologics has named Dr Daniel C Smith chief scientific officer. He will be responsible for enhancing Cobra's DNA, virus, microbial and mammalian proteins research and development platforms. Prior to joining the Sweden and UK-situated company Dr Smith was a knowledge transfer manager with bioProcessUK at the HealthTech and Medicines Knowledge Transfer Network.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.